Objective: The marked weight loss induced by Roux-en-Y gastric bypass (RYGBP) for morbid obesity is still incompletely understood. It has been suggested that, besides the restriction imposed by the surgical procedure, alterations in gut regulatory peptides signaling the brain might contribute. The aim of this study was to measure the putative satiety peptides peptide YY (PYY), glucagon-like peptide-1 (GLP-1), pancreatic polypeptide (PP) and pro-neurotensin (pro-NT) in response to fasting and feeding. Design: The study is a cross-sectional study. After a prolonged overnight 14 h fast, a standardized mixed meal (574 kcal) was provided. Blood samples for peptide measurements were obtained before and after the meal. Subjects: Forty subjects (20 males and females) were included; 10 morbidly obese; (mean age 41 ± 7 years; mean BMI 44 ± 3 kg/m 2 ), 10 operated with RYGBP (age 45 ± 5 years; BMI 35 ± 6 kg/m 2 ), 10 aged-matched lean (age 44 ± 5 years; BMI 24 ± 3 kg/m 2 ) and 10 young lean subjects (age 26 ± 2 years; BMI 23 ± 2 kg/m 2 ). Measurements: Plasma concentrations of PYY, GLP-1, PP and pro-NT were obtained. Results: PYY levels increased more in the RYGBP group than in the other groups after the test meal. GLP-1 levels rose in the RYGBP patients, with a small increase seen in the age-matched lean group. PP concentrations increased similarly in all groups postprandially. Pro-NT levels were highest in surgical patients, with no meal effect. Conclusion: RYGBP subjects displayed exaggerated PYY and GLP-1 responses to a standardized meal and demonstrated higher pro-NT levels both pre-and postprandially. The findings indicate that possibly the alterations in gut peptide secretion may promote weight loss after gastric bypass surgery.
Introduction
Bariatric surgery is the most effective treatment for achieving significant long-term weight loss and improved quality of life in morbidly obese humans. 1, 2 Roux-en-Y gastric bypass (RYGBP) comprises both restrictive and malabsorptive components. The mechanisms behind the marked weight loss are not fully explored. An increasing number of protein hormones, involved in appetite regulation and energy homeostasis, have been isolated from the gastrointestinal tract. The aim of this study was to examine the satiety peptides peptide YY (PYY), glucagon-like peptide-1 (GLP-1), pancreatic polypeptide (PP) and pro-neurotensin (pro-NT) in response to a standardized mixed meal in operated, obese and normal weight individuals. PYY, a 36 amino acid and a member of the neuropeptide Y and PP family, is found in the greatest concentrations in the terminal ileum, colon and rectum.
3 PYY3-36 release is stimulated by intraluminal nutrients, including glucose, bile salts, lipids, short-chain fatty acids and amino acids. PYY3-36 has been reported to suppress appetite and stimulate weight loss through the arcuate nucleus Y2 receptors in the hypothalamus. 4, 5 PYY also inhibits gastric emptying and delays transit time. 6 A postprandial rise in PYY concentrations has been demonstrated in healthy normal-weight individuals but not in anorectic or obese subjects. 7 GLP-1 is a 29 amino acid peptide co-localized with PYY in L-type endocrine cells of the gastrointestinal mucosa, 3 and like PYY, it lowers food intake in rats 8, 9 and humans [10] [11] [12] [13] in supraphysiological concentrations. One study assessed appetite and found a tendency for reduced hunger and prospective consumption, as well as increased satiety during the infusion of GLP-1 in type 2 diabetic patients. 14 A metaanalysis indicated that an intravenous GLP-1 infusion reduced energy intake in lean and overweight humans. Also affected was gastric emptying, slowed by GLP-1.
15
PP has 36 amino acids and is localized almost entirely to the PP cells in the islets of Langerhans, and is released during eating, in particular by protein-and fat-rich foods. 16 PP inhibits gastric and pancreatic exocrine secretions, gastrointestinal motility and augments the inhibitory effects of insulin on hepatic glucose production. PP release is under cholinergic control as evidenced by a blunted meal response during atropine blockade 17 or vagotomy. 18 Increases in PP concentrations have been used as a measure of vagal efferent function during sham feeding experiments. 19, 20 The most recently studied satiety factor is pro-NT, a precursor for the mature but unstable NT, first cloned from the canine intestine and bovine brain. 21 The 170 amino acid pro-NT molecule is secreted from N cells in the jejunum, ileum, duodenum, colon and the brain. Pro-NT/NT is released after food intake, especially fat, and regulates gastrointestinal motility, and pancreatic and biliary secretion. 22 In an earlier human study, NT levels in eight morbidly obese patients were undetectable during an oral glucose tolerance test (OGTT) but 3 months after gastrojejunostomy, the OGTT was repeated and seven of eight patients showed a significant release of NT. 23 Here, we focus on the putative satiety factors, such as PYY, GLP-1, PP and pro-NT in morbidly obese, RYGBP-operated and normal weight subjects during preprandial fasting, as well as the response to a standardized mixed meal.
Materials and methods
Study subjects and study protocol A total of 40 subjects were recruited for the study and divided into four groups each comprising 5 men and 5 women; 10 morbidly obese (mean age 41±7 years; mean BMI 44±3 kg/m 2 ), 10 RYGBP-operated (age 45±5 years; BMI 35±6 kg/m 2 ), 10 lean age-matched (age 44 ± 5 years; BMI 24 ± 3 kg/m 2 ) and 10 young lean subjects (age 26 ± 2 years; BMI 23 ± 2 kg/m 2 ). The RYGBP procedure was performed at the Department of Surgery at Uppsala University Hospital. Subjects were investigated a mean of 43 months (range 25-53) after the surgical procedure. RYGBP excludes the stomach, duodenum and proximal jejunum from the passage of food. The new stomach is a small 15-ml pouch created along the lesser curvature and totally separated from the original stomach. The small bowel is divided 30 cm distal to the ligament of Treitz and a 50-cm long Roux limb is connected to the pouch directly below the esophagus. Small bowel continuity is maintained by an enteroenterostomy, creating a Y-shaped junction where food meets gastric acid and bile.
Subjects presented to the Outpatient Clinic for Obesity Care, Uppsala University Hospital after an overnight fast and continued fasting until a standardized meal was served at 1300 hours. The meal consisted of 574 kcal (21% fat, 18% protein and 61% carbohydrates). Blood samples were drawn at 0800, 1000, 1200, 1300, 1330, 1400, 1430, 1500 and 1600 hours and then stored at À70 1C prior to laboratory analyses. and GLP-1 7-37 . The detection limit was 2 pM, specificity 100% for human GLP-1 and GLP-1 7-37 , whereas o0.1% for human GLP-1 . Inter-and intra-assays CVs were o13%.
Analyses
PP was assayed in serum with a competitive radioimmunoassay (Euro-Diagnostica AB, Malmö, Sweden) using rabbit antiserum, 125 I-labelled human PP and the double antibody-polyethylene glycol precipitation technique. Human, synthetic PP was used for standardization. The lowest detectable concentration is 3 pmol l À1 . Inter-and intra-assays CVs were o3.5%. Pro-NT was measured in serum by Ernst et al. 24 at
SphingoTec GmbH (Borgsdorf, Germany), using a recent chemiluminometric sandwich immunoassay to detect a pro-NT precursor fragment (pro-NT 1-117). Sensitivity of the assay was 10 pmol l
À1
, CV o20% for interassay and o10% for intra-assay. Measurements of pro-NT had to be limited to three serum samples from each individual in the age-matched groups; drawn at 1300 hours prior to the test meal, and 30 and 90 min after the meal. The time points were chosen based on observations obtained in prior assays of PYY, GLP-1 and PP.
Statistics
Age and BMI are expressed as mean and s.d., whereas the peptides displayed skewed data and were logarithmically transformed prior to analyses. Peptide results are therefore given as geometric mean and s.e. with Po0.05 as significant. Analyses by analysis of variance were carried out to detect inter-and intragroup changes with time. The Bonferroni post hoc test was used to detect the effect of fasting and the meal within the groups. Statview 5.0 for Windows (SAS Institute Inc. Cary, NC, USA) was used for these calculations. Paired
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We certify that all applicable institutional and governmental regulations concerning the ethical use of human volunteers were followed during this research. All participating subjects received a patient information sheet and completed an informed consent form approved by the Uppsala University Ethics Committee.
Results

PYY
During the preprandial period, there was a continuous decline in PYY concentrations in the obese and two lean groups. After the extended overnight fast at 1300 hours, the RYGBP patients had higher PYY concentrations than the other groups (P ¼ 0.008). Upon feeding, an exaggerated postprandial increase in PYY concentrations was seen in the RYGBP group as compared with the other groups ( Figure 1 ).
GLP-1
GLP-1 tended to be higher in the two normal-weight groups during the experiment (P ¼ 0.11), whereas no difference was seen in GLP-1 concentrations between the four groups after the extended fast. Postprandial GLP-1 concentrations were markedly elevated in the RYGBP group (P ¼ 0.01). A small increase was seen also in the older lean subjects (P ¼ 0.05) (Figure 2 ).
PP
After the extended fast, difference was detected between the groups. Postprandial PP concentrations increased significantly in all subjects (Figure 3) . PP tended to increase to a lesser extent in the RYGBP group (P ¼ NS).
Pro-NT Pro-NT concentrations, measured in the three age-matched groups, did not change with food intake in the RYGBP patients. In contrast, a postprandial increase occurred in both lean and obese groups. At 1300 hours, before the meal, the RYGBP group had higher pro-NT concentrations than both obese and lean subjects (P ¼ 0.04 and P ¼ 0.0001, respectively). Obese individuals also had higher concentrations than lean controls (Table 1 ). Gut regulatory peptides and gastric bypass C Holdstock et al
Discussion
In this study, we demonstrated that a standardized mixed meal stimulated a hyperresponse of the putative satiety peptides PYY and GLP-1 in the RYGBP group. Furthermore and not reported earlier, we observed that basal pro-NT concentrations were 4-to 6-fold higher in this group, as compared with obese and age-matched lean subjects, and were not affected by food intake. These findings suggest that RYGBP patients have a high 'satiety peptide tone' throughout the day. PP concentrations were elevated postprandially and similar in all four groups. female adolescents, with a trend towards higher concentrations in the obese. 7 In this study, we observed that PYY concentrations tended to be higher in the obese group in the morning, but not after the prolonged fast. Taken together, there is no consistent evidence of a simple relationship between baseline PYY and BMI in a given individual. A recent study by Morinigo et al. 32 in obese subjects supports our findings. Six weeks after RYGBP surgery, the area under the curve (AUCs) for PYY and GLP-1 were higher in response to a standardized meal in operated subjects than in the BMI-matched (43 kg/m 2 ) control group. The increase was accompanied by decreases in fasting and postprandial hunger and an increase in satiety. In our study, the PYY and Gut regulatory peptides and gastric bypass C Holdstock et al GLP-1 responses were larger in the RYGBP group than in the age-matched control group with a lower BMI. The results by Morinigo et al. 32 and the results in this study thus point to a mechanism of appetite regulation dependent on the surgical procedure than on BMI. A limitation of the present crosssectional study is that we did not assess satiety score and hunger feelings in association with 'satiety markers'. In another study, AUCs for PYY and GLP-1 after a mixed meal increased progressively from 1 to 6 months in six RYGBP patients, with satiety scores higher 1 month after surgery and maintained for 6 months. It was suggested that lack of an augmented appetite and food intake is a part of a counterregulatory response, which may be explained by gut adaptation and concurrent rises in PYY and GLP-1 concentrations, promoting satiety. 33 Finally, a recent report of 228 subjects who had sleeve gastrectomy, omentectomy and initial jejunectomy demonstrated increases in PYY and GLP-1 levels postprandially in a subgroup of 17 subjects, which was accompanied by earlier satiety, no adverse effects and better quality of life 5 years after surgery. 34 There are discrepancies regarding the potential role of PYY as a satiety factor. Peripheral injections of PYY 3-36 into rats inhibited food intake and reduced weight gain, whereas an infusion into humans reduced appetite and food intake, 4 as well as decreased caloric intake in obese and lean subjects. 28 Another study described greater feeding inhibition by combined peripheral administration of PYY and GLP-1 in rodents, and greater reduction in energy intake in humans 35 compared with either treatment given alone.
Sloth et al. 36 recently reported that subcutaneous administration into human subjects of increasing doses of PYY resulted in greater satiety and less hunger, thirst and ability to consume. In contrast, 12 independent study groups reported that they were unable to replicate the anorexigenic or weight reducing effects of PYY in rodents. 37 In humans, a role for endogenous PYY has been suggested because changes in plasma PYY concentrations after a test meal were found to be associated with changes in self-reported hunger or satiety. 7, [38] [39] [40] le Roux et al. 38 described that double the meal energy content was required to achieve equivalent PYY levels in obese as in normal-weight subjects. 19, 20, 45 We have earlier reported that ghrelin and PP decreased transiently after RYGBP surgery, and then subsequently increased as weight loss ensued. We concluded that the rapid reduction in ghrelin after RYGBP was possibly due to temporary vagal dysfunction. 46 In this study, PP increased in a similar way in all groups postprandially but to a slightly lesser extent in the RYGBP group. Although this change was insignificant, it potentially indicates some degree of vagal nerve dysfunction after gastric bypass surgery. The pro-NT preprandial concentrations were higher in the RYGBP group than in their lean and obese counterparts. In this study, increases were seen postprandially in the lean and obese groups, whereas there was no change in the RYGBP group. One study reported lower pro-NT concentrations 3 and 6 months after gastric banding surgery than in the gastric bypass patients. Furthermore, pro-NT concentrations increased postoperatively at 24 months in the gastric bypass patients, whereas this change was undetectable in the gastric banding group. 47 In this study, pro-NT did not change postprandially in the RYGBP group, which differed from the postprandial changes seen in PYY and GLP-1. Despite the extended fast pro-NT concentrations were high in the RYGBP group, a phenomenon possibly linked to satiety that needs to be further explored. In this regard, the observation made in rats that NT contributes to leptin's inhibitory action on feeding 48 could be of relevance.
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In conclusion, we found that RYGBP subjects displayed exaggerated PYY and GLP-1 responses to a standardized mixed meal. In addition, we observed higher pro-NT concentrations in the RYGBP group both before and after the meal. Collectively, the findings may suggest that some of the alterations in PYY, GLP-1 and pro-NT contribute to the marked and sustained weight loss and improvements in metabolism seen after gastric bypass surgery.
